Kimberly Popovits

Committed to changing the paradigm of cancer care, Kim Popovits led Genomic Health in revolutionizing the treatment of cancer through genomic-based diagnostic tests for breast, colon, and prostate cancers that address the over-treatment and optimal treatment of early-stage cancer, one of the greatest issues in health care today. She now serves as a board member with 10x Genomics. Kim served as Genomic Health’s Chairman of the Board beginning in 2012, as its CEO and President beginning in 2009, and as its President and Chief Operating Officer beginning in 2002.